AnaptysBio Inc - Company Profile

Powered by

All the sales intelligence you need on AnaptysBio Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how AnaptysBio Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with AnaptysBio Inc.

Back to companies

AnaptysBio Inc: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on AnaptysBio Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
US20230391872A1 Application B and t lymphocyte attenuator (BTLA) modulators and method of using same A61P37/02; C07K16/2818; C07K2317/565; G01N33/53 December 07, 2023
WO2023212611A1 Application B and t lymphocyte attenuator (BTLA) modulators and method of using same A61K2039/505; A61K2039/545; A61P37/06; C07K16/2818; C07K2317/33; C07K2317/34; C07K2317/56; C07K2317/565; C07K2317/92 November 02, 2023
US20230331843A1 Application Antibodies directed against programmed death-1(PD-1) A61K2039/507; A61K39/3955; A61P31/04; A61P31/12; A61P31/16; A61P31/18; A61P31/20; A61P35/00; C07K16/28; C07K16/2803; C07K16/2818; C07K2317/24; C07K2317/33; C07K2317/565; C07K2317/76; C07K2317/92; C07K2317/94; Y02A50/30 October 19, 2023
CA3041684C Grant Antibodies directed against programmed death- 1 (PD-1) C12N15/63; A61K2039/505; A61K39/3955; A61K45/06; A61P1/04; A61P17/00; A61P17/06; A61P19/02; A61P25/00; A61P29/00; A61P3/10; A61P31/00; A61P31/04; A61P31/12; A61P31/14; A61P31/16; A61P31/18; A61P31/20; A61P35/00; A61P35/02; A61P37/02; A61P37/04; A61P43/00; C07K16/2803; C07K16/2818; C07K2317/33; C07K2317/41; C07K2317/524; C07K2317/53; C07K2317/56; C07K2317/76; C07K2317/92; Y02A50/30 September 26, 2023
CN116685603A Application B and t lymphocyte attenuation factor (BTLA) modulators and methods of use thereof Y02A50/30 September 01, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer